Morphogenesis CEO Patricia Lawman Recognized As Health Care Innovator 2020 on Tampa Bay Business Journal (Tampa Bay Business Journal)

Morphogenesis CEO Patricia Lawman Recognized As Health Care Innovator 2020 on Tampa Bay Business Journal

The Tampa Bay Business Journal recognized Patricia Lawman, founder and chief executive officer of UF startup and UF Innovate | Sid Martin Biotech graduate company  Morphogenesis, Inc., a clinical-stage immunotherapy company headquartered in Tampa, for being part of the region’s top health care innovators. The feature was part of the Florida Business Journal’s statewide Future of Health Care special publication published October 23, 2020.

“On a personal level, the most important lesson I’ve learned to date is to pick the people you associate with very wisely — that applies across the board from team members, to consultants, to vendors, to board members,” Lawman said during the interview. “Honesty and integrity trump ‘smart talk’ and egos every time. Scientifically, I’ve learned that simple solutions, although they may not sound as impressive as complicated and expensive approaches, usually work out better. Our cancer immunomodulators couldn’t be more simple in concept or wide in applicability. Now we just need to see how far we can take it in treating the plethora of human cancers. We have some very innovative ideas on how to make these products treat different cancers and even different stages of these various cancers.”

Learn more about Morphogenesis CEO Patricia Lawman Recognized As Health Care Innovator 2020 on Tampa Bay Business Journal. – Article behind a paywall.
X